US4340738A
Expired / Lapsed
US
⏱️ 0.0 years remaining
2,3-Dihydro-imidazo[2,1-b]benzothiazoles
Assignee: Janssen Pharmaceutica NV
•
Filing: 1981-01-09
•
Granted: 1982-07-20
•
Expires: 2001-01-09
Abstract
Abstract This invention relates to a novel series of 2,3-dihydroimidazo[2,1-b]benzothiazoles which display monoamine oxidase inhibiting activities.
Inventors
- 👤 Victor Sipido
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 02:00
CPC Classifications
C; C07; C07D; C07D513/00; C07D513/02; C07D513/04; C07C; C07C205/00; C07C205/07; C07C205/11; C07C205/12; C07C335/00; C07C335/04; C07C335/16; C07D277/00; C07D277/60; C07D277/62; C07D277/68; C07D277/82; C07D277/84
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
321 words
A chemical compound selected from the group consisting of a 2,3-dihydroimidazo[2,1-b]benzothiazole which may structurally by represented by the formula ##STR41## and the pharmaceutically acceptable acid addition salts thereof, the pharmaceutically acceptable imidazo[2,1-b]benzothiazolium salts of formula ##STR42## and metal salt complexes thereof with a transition metal salt wherein: R 1 and R 3 are each independently selected from the group consisting of hydrogen and lower alkyl; R 2 and R 4 are each independently selected from the group consisting of hydrogen, lower alkyl, aryl, aryllower alkyl, lower alkyloxylower alkyl or aryloxylower alkyl; R 5 , R 6 , R 7 and R 8 are each independently selected from the group consisting of hydrogen; nitro; alkyl having from 1 to 20 carbon atoms; cycloalkyl having from 3 to 6 carbon atoms; hydroxy; lower alkyloxy; aryloxy; α-hydroxyarylmethyl; amino; mono- and dialkyl-amino; mono-, di- and trihalo-lower alkyl-amino; lower alkenylamino; lower alkynylamino (aryllower alkyl)amino; (lower alkyloxy-lower alkyl)amino; (hydroxy-lower alkyl)amino; (aryloxy-lower alkyl)amino; [mono- and di(lower alkyl)amino-lower alkyl]amino; lower alkanoylamino; N-(lower alkyl)-lower alkanoylamino; aminocarbonylamino; (1-lower alkyl-4-piperidinyl)amino; cycloalkylamino wherein said cycloalkyl represents a mono-, bi-, tri- or tetracyclic hydrocarbon radical having from 3 to 10 carbon atoms; and a radical of the formula ##STR43## wherein R 10 is selected from the group consisting of hydrogen, lower alkyl, lower alkenyl and lower alkynyl; or when taken together R 5 and R 6 , R 6 and R 7 , or R 7 and R 8 may form a tri- or tetramethylene bridge or complete a fused benzene nucleus; R 9 is a member selected from the group consisting of lower alkyl, lower alkenyl, lower alkynyl and aryl lower alkyl; and X is a pharmaceutically acceptable anion and n represents the valency of the anion; wherein aryl as used in the foregoing definitions is phenyl, optionally substituted with 1 to 3 substituents each independently selected from the group consisting of halo, lower alkyl, lower alkyloxy and trifluoromethyl; and aroyl is arylcarbonyl.
Claim 2
Dependent Claim
321 words
A chemical compound selected from the group consisting of a 2,3-dihydroimidazo[2,1-b]benzothiazole which may structurally by represented by the formula ##STR41## and the pharmaceutically acceptable acid addition salts thereof, the pharmaceutically acceptable imidazo[2,1-b]benzothiazolium salts of formula ##STR42## and metal salt complexes thereof with a transition metal salt wherein: R 1 and R 3 are each independently selected from the group consisting of hydrogen and lower alkyl; R 2 and R 4 are each independently selected from the group consisting of hydrogen, lower alkyl, aryl, aryllower alkyl, lower alkyloxylower alkyl or aryloxylower alkyl; R 5 , R 6 , R 7 and R 8 are each independently selected from the group consisting of hydrogen; nitro; alkyl having from 1 to 20 carbon atoms; cycloalkyl having from 3 to 6 carbon atoms; hydroxy; lower alkyloxy; aryloxy; α-hydroxyarylmethyl; amino; mono- and dialkyl-amino; mono-, di- and trihalo-lower alkyl-amino; lower alkenylamino; lower alkynylamino (aryllower alkyl)amino; (lower alkyloxy-lower alkyl)amino; (hydroxy-lower alkyl)amino; (aryloxy-lower alkyl)amino; [mono- and di(lower alkyl)amino-lower alkyl]amino; lower alkanoylamino; N-(lower alkyl)-lower alkanoylamino; aminocarbonylamino; (1-lower alkyl-4-piperidinyl)amino; cycloalkylamino wherein said cycloalkyl represents a mono-, bi-, tri- or tetracyclic hydrocarbon radical having from 3 to 10 carbon atoms; and a radical of the formula ##STR43## wherein R 10 is selected from the group consisting of hydrogen, lower alkyl, lower alkenyl and lower alkynyl; or when taken together R 5 and R 6 , R 6 and R 7 , or R 7 and R 8 may form a tri- or tetramethylene bridge or complete a fused benzene nucleus; R 9 is a member selected from the group consisting of lower alkyl, lower alkenyl, lower alkynyl and aryl lower alkyl; and X is a pharmaceutically acceptable anion and n represents the valency of the anion; wherein aryl as used in the foregoing definitions is phenyl, optionally substituted with 1 to 3 substituents each independently selected from the group consisting of halo, lower alkyl, lower alkyloxy and trifluoromethyl; and aroyl is arylcarbonyl.
Claim 3
Dependent Claim
35 words
A chemical compound selected from the group consisting of N-ethyl-2,3-dihydroimidazo[2,1-b]benzothiazol-6-amine, the pharmaceutically acceptable acid addition salts thereof, the pharmaceutically acceptable corresponding imidazo[2,1-b]benzothiazolium salts thereof and the metal salt complexes thereof with a transition metal salt.
Claim 4
Dependent Claim
35 words
A chemical compound selected from the group consisting of N-ethyl-2,3-dihydroimidazo[2,1-b]benzothiazol-6-amine, the pharmaceutically acceptable acid addition salts thereof, the pharmaceutically acceptable corresponding imidazo[2,1-b]benzothiazolium salts thereof and the metal salt complexes thereof with a transition metal salt.
References Cited (Backward Citations)
US4076817A
Cited
US4262004A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-07-19 | 1986-01-18 | 1986-07-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-07-19 | 1990-01-18 | 1990-07-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-07-19 | 1994-01-18 | 1994-07-20 | $7700.00 | Window Closed / Lapsed |